397 related articles for article (PubMed ID: 28032858)
21. MicroRNA-26a/-26b-COX-2-MIP-2 Loop Regulates Allergic Inflammation and Allergic Inflammation-promoted Enhanced Tumorigenic and Metastatic Potential of Cancer Cells.
Kwon Y; Kim Y; Eom S; Kim M; Park D; Kim H; Noh K; Lee H; Lee YS; Choe J; Kim YM; Jeoung D
J Biol Chem; 2015 May; 290(22):14245-66. PubMed ID: 25907560
[TBL] [Abstract][Full Text] [Related]
22. MiRNA expression profiles reveal the involvement of miR-26a, miR-548l and miR-34a in hepatocellular carcinoma progression through regulation of ST3GAL5.
Cai H; Zhou H; Miao Y; Li N; Zhao L; Jia L
Lab Invest; 2017 May; 97(5):530-542. PubMed ID: 28218742
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-223 Targeting STIM1 Inhibits the Biological Behavior of Breast Cancer.
Yang Y; Jiang Z; Ma N; Wang B; Liu J; Zhang L; Gu L
Cell Physiol Biochem; 2018; 45(2):856-866. PubMed ID: 29414804
[TBL] [Abstract][Full Text] [Related]
24. miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4.
Zhao L; Feng X; Song X; Zhou H; Zhao Y; Cheng L; Jia L
Oncol Rep; 2016 Aug; 36(2):1007-15. PubMed ID: 27375041
[TBL] [Abstract][Full Text] [Related]
25. Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer.
Miyamoto K; Seki N; Matsushita R; Yonemori M; Yoshino H; Nakagawa M; Enokida H
Br J Cancer; 2016 Jul; 115(3):354-63. PubMed ID: 27310702
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA regulation of progesterone receptor in breast cancer.
Gilam A; Shai A; Ashkenazi I; Sarid LA; Drobot A; Bickel A; Shomron N
Oncotarget; 2017 Apr; 8(16):25963-25976. PubMed ID: 28404930
[TBL] [Abstract][Full Text] [Related]
27. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.
Feng X; Zhao L; Gao S; Song X; Dong W; Zhao Y; Zhou H; Cheng L; Miao X; Jia L
Gene; 2016 Mar; 578(2):232-41. PubMed ID: 26701615
[TBL] [Abstract][Full Text] [Related]
28. miR-410-3p suppresses breast cancer progression by targeting Snail.
Zhang YF; Yu Y; Song WZ; Zhang RM; Jin S; Bai JW; Kang HB; Wang X; Cao XC
Oncol Rep; 2016 Jul; 36(1):480-6. PubMed ID: 27221455
[TBL] [Abstract][Full Text] [Related]
29. Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia.
Ma H; Zhou H; Song X; Shi S; Zhang J; Jia L
Oncogene; 2015 Feb; 34(6):726-40. PubMed ID: 24531716
[TBL] [Abstract][Full Text] [Related]
30. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.
Pan Y; Li J; Zhang Y; Wang N; Liang H; Liu Y; Zhang CY; Zen K; Gu H
Sci Rep; 2016 May; 6():25798. PubMed ID: 27174021
[TBL] [Abstract][Full Text] [Related]
31. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
32. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer.
Ding Q; Wang Y; Zuo Z; Gong Y; Krishnamurthy S; Li CW; Lai YJ; Wei W; Wang J; Manyam GC; Diao L; Zhang X; Lin F; Symmans WF; Sun L; Liu CG; Liu X; Debeb BG; Ueno NT; Harano K; Alvarez RH; Wu Y; Cristofanilli M; Huo L
Hum Pathol; 2018 Jul; 77():121-129. PubMed ID: 29689244
[TBL] [Abstract][Full Text] [Related]
34. miR-4262 Promotes Proliferation and Invasion of Human Breast Cancer Cells Through Directly Targeting KLF6 and KLF15.
Wang K; Ren Y; Liu Y; Zhang J; He JJ
Oncol Res; 2017 Jan; 25(2):277-283. PubMed ID: 27629257
[TBL] [Abstract][Full Text] [Related]
35. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
[TBL] [Abstract][Full Text] [Related]
36. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
John Clotaire DZ; Zhang B; Wei N; Gao R; Zhao F; Wang Y; Lei M; Huang W
Biochem Biophys Res Commun; 2016 Mar; 472(1):194-200. PubMed ID: 26920049
[TBL] [Abstract][Full Text] [Related]
37. MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion.
Verghese ET; Drury R; Green CA; Holliday DL; Lu X; Nash C; Speirs V; Thorne JL; Thygesen HH; Zougman A; Hull MA; Hanby AM; Hughes TA
J Pathol; 2013 Nov; 231(3):388-99. PubMed ID: 23939832
[TBL] [Abstract][Full Text] [Related]
38. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.
Du JY; Wang LF; Wang Q; Yu LD
Oncol Rep; 2015 Apr; 33(4):1890-8. PubMed ID: 25672572
[TBL] [Abstract][Full Text] [Related]
39. MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2.
Li H; Sun Q; Han B; Yu X; Hu B; Hu S
Int J Clin Exp Pathol; 2015; 8(5):4782-90. PubMed ID: 26191168
[TBL] [Abstract][Full Text] [Related]
40. miR-182 and miR-135b Mediate the Tumorigenesis and Invasiveness of Colorectal Cancer Cells via Targeting ST6GALNAC2 and PI3K/AKT Pathway.
Jia L; Luo S; Ren X; Li Y; Hu J; Liu B; Zhao L; Shan Y; Zhou H
Dig Dis Sci; 2017 Dec; 62(12):3447-3459. PubMed ID: 29030743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
